Diabetes medication experts focus on practical access and pharmacist counseling considerations for adults on obesity medication.
|Articles|November 20, 2006
Anticancer drug treats skin lymphoma
The recently approved Zolinza (vorinostat), the first anticancer drug to be developed by Merck & Co. in 20 years, targets a little-known malignancy that's often mistaken for eczema or psoriasis. Vorinostat, also known as suberoylanilide hydroxamic acid (SAHA), is indicated for the treatment of cutaneous manifestations in patients with cutaneous T-cell lymphoma (CTCL), a rare form of non-Hodgkin's lymphoma, who have progressive, persistent, or recurrent disease on or following two systemic therapies.
Advertisement
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
SubscribeAdvertisement
Related to this article
The oral tablet formulation was approved for adults with weakened immune systems who have not responded to other therapy.
Melissa McGivney, PharmD, FAPhA, FCCP, helps celebrate American Pharmacists Month and the innovation driving the profession forward amongst US communities.
Teva Pharmaceuticals’ new olanzapine option is the first once-monthly subcutaneous injectable on the market for schizophrenia.
The novel tool can be used to inform vaccine policy, monitor impact, and essentially strengthen overall surveillance.
Melissa McGivney, PharmD, FAPhA, FCCP, discusses her career journey from her local pharmacy to a national leadership role with the American Pharmacists Association.
Researchers evaluate peer-reviewed literature on interventions to improve vaccine uptake among thousands of US adults studied between 2010 and 2015.
Infectious disease readiness depends on rehearsed workflows, bidirectional public health communication, and rapid access to care.
Advertisement
Advertisement